Chronic hypercapnic respiratory failure and non-invasive ventilation in people with chronic obstructive pulmonary disease.
Umur HatipoğluLoutfi Sami AboussouanPublished in: BMJ medicine (2022)
Chronic obstructive pulmonary disease (COPD) should no longer be seen as a condition for which little can be done. Novel pharmacotherapeutic interventions, surgical and procedural advances, and respiratory assist devices have provided numerous ways to help patients with COPD and treatable traits. For nearly 30 years, non-invasive ventilation, the application of positive pressure through a mask interface placed outside of the airway, has been the cornerstone for treatment of acute hypercapnic respiratory failure due to COPD exacerbation. Clinical trials indicate that this intervention could benefit patients with COPD and chronic hypercapnic respiratory failure in a stable state. This narrative review aims to provide the necessary background for internists to consider this therapeutic option for their COPD patients. We discuss the mechanism of action and implementation, and provide a glimpse into the future of this promising intervention.
Keyphrases
- respiratory failure
- chronic obstructive pulmonary disease
- lung function
- extracorporeal membrane oxygenation
- mechanical ventilation
- clinical trial
- randomized controlled trial
- acute respiratory distress syndrome
- end stage renal disease
- primary care
- healthcare
- physical activity
- ejection fraction
- newly diagnosed
- intensive care unit
- gene expression
- prognostic factors
- cystic fibrosis
- quality improvement
- dna methylation
- open label
- phase ii